These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 6797744)
21. The importance of the chemical state of 99mTc radiopharmaceuticals: an effective tumor imaging form of 99mTc bleomycin. Yokoyama A; Terauchi Y; Horiuchi K; Okumura S; Saito Y; Tanaka H; Odori T; Morita R; Mori T; Torizuka K Int J Appl Radiat Isot; 1978 Oct; 29(9-10):549-55. PubMed ID: 85607 [No Abstract] [Full Text] [Related]
22. An imaging study using laminin peptide 99mTc-YIGSR in mice bearing Ehrlich ascites tumour. Hu J; Zhang YX; Lan XL; Qin GM; Zhang J; Hu ZH Chin Med J (Engl); 2005 May; 118(9):753-8. PubMed ID: 15899138 [TBL] [Abstract][Full Text] [Related]
23. Preparation and pharmacological evaluation of a new radiopharmaceutical, technetium-99m-5-fluorouracil, for tumor scintigraphy. Kumar S; Kumar Mishra A; Chhikara BS; Chuttani K; Kumar Sharma R Hell J Nucl Med; 2008; 11(2):91-5. PubMed ID: 18815662 [TBL] [Abstract][Full Text] [Related]
24. [Feasibility of apoptosis-imaging agent 99mTc-HYNIC-annexin V in early assessment of chemotherapeutic effect on tumor models]. Lan XL; Zhang YX; He Y; Sun X; An R; Gao ZR; Cao GX Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):737-40. PubMed ID: 19173800 [TBL] [Abstract][Full Text] [Related]
25. Development of new radiopharmaceuticals--technetium aminopolycarboxylate complexes. Havránek E; Bumbálová A; Krenek P; Komová M; Beláková M Pharmazie; 1994 May; 49(5):369-70. PubMed ID: 8016183 [No Abstract] [Full Text] [Related]
26. What is the source of the skeletal affinity of 99mTc-V-DMSA? Athanasoulis T; Koutsikos J; Zerva C Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1673-4; author reply 1675-6. PubMed ID: 15452672 [No Abstract] [Full Text] [Related]
27. Limitations and pitfalls of 99mTc-EDDA/HYNIC-TOC (Tektrotyd) scintigraphy. Garai I; Barna S; Nagy G; Forgacs A Nucl Med Rev Cent East Eur; 2016; 19(2):93-8. PubMed ID: 27479887 [TBL] [Abstract][Full Text] [Related]
28. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging. Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877 [TBL] [Abstract][Full Text] [Related]
29. Technetium-99m-labeling and synthesis of thymidine analogs: potential candidates for tumor imaging. Teng B; Bai Y; Chang Y; Chen S; Li Z Bioorg Med Chem Lett; 2007 Jun; 17(12):3440-4. PubMed ID: 17449246 [TBL] [Abstract][Full Text] [Related]
30. Scintigraphic imaging of the hypoxia marker (99m)technetium-labeled 2,2'-(1,4-diaminobutane)bis(2-methyl-3-butanone) dioxime (99mTc-labeled HL-91; prognox): noninvasive detection of tumor response to the antivascular agent 5,6-dimethylxanthenone-4-acetic acid. Siim BG; Laux WT; Rutland MD; Palmer BN; Wilson WR Cancer Res; 2000 Aug; 60(16):4582-8. PubMed ID: 10969810 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of 99mTc-labeled amino acids as radiopharmaceuticals. VI. N-pyridoxylidenehydrazine-N',N'-diacetic acid. Matsushima Y; Mori S; Karube Y; Sugata S; Kono A; Kunitoku H; Yamamoto Y; Miyake Y; Kojima M Chem Pharm Bull (Tokyo); 1984 Jun; 32(6):2262-6. PubMed ID: 6488399 [No Abstract] [Full Text] [Related]
33. [Experimental on the application of liposome to tumor imaging agents]. Ogihara I; Kojima S; Kubodera A Kaku Igaku; 1984 Jul; 21(7):871-4. PubMed ID: 6492481 [No Abstract] [Full Text] [Related]
34. Design, synthesis, and biological evaluation of catecholamine vehicle for studying dopaminergic system. Singh P; Kumar V; Aggarwal S; Tiwari AK; Chuttani K; Pratap R; Mishra AK Chem Biol Drug Des; 2013 Aug; 82(2):226-32. PubMed ID: 23601203 [TBL] [Abstract][Full Text] [Related]
35. [Non-visualization of the hepatic image on 99mTc-colloid scintigraphy in liver cirrhosis: a case report]. Wada M; Oshiumi Y; Ichiya Y; Ayabe Y; Kuwabara Y; Yoshida M; Hayashi T; Hirata H; Konishi K; Matsuura K Kaku Igaku; 1982 Dec; 19(10):1585-8. PubMed ID: 7169692 [No Abstract] [Full Text] [Related]
36. [Scintiscan visualization of acute myocardial infarction using 99mTc-labelled gluconate (author's transl)]. Duska F Cas Lek Cesk; 1982 Jan; 121(2):38-40. PubMed ID: 7060062 [No Abstract] [Full Text] [Related]
37. Targeted imaging of gastrin-releasing peptide receptors with 99mTc-EDDA/HYNIC-[Lys3]-bombesin: biokinetics and dosimetry in women. Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Pichardo-Romero PA Nucl Med Commun; 2008 Aug; 29(8):741-7. PubMed ID: 18753829 [TBL] [Abstract][Full Text] [Related]
38. 99mTc-EDDA/HYNIC-TOC in the diagnosis of differentiated thyroid carcinoma refractory to radioiodine treatment. Czepczyński R; Gryczyńska M; Ruchała M Nucl Med Rev Cent East Eur; 2016; 19(2):67-73. PubMed ID: 27479883 [TBL] [Abstract][Full Text] [Related]
39. Synthesis of oxytocin HYNIC derivatives as potential diagnostic agents for breast cancer. Miranda-Olvera AD; Ferro-Flores G; Pedraza-López M; de Murphy CA; De León-Rodríguez LM Bioconjug Chem; 2007; 18(5):1560-7. PubMed ID: 17665873 [TBL] [Abstract][Full Text] [Related]
40. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides. Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]